“COMPARATIVE PHARMACOECONOMIC EVALUATION OF THE USE OF AFATINIB AND GEFITINIB IN THERAPY FOR LUNG CANCER”, Вопр. онкол., vol. 63, no. 1, pp. 38–51, Jan. 2017, doi: 10.37469/0507-3758-2017-63-1-38-51.